SIGA Technologies, Inc. (SIGA) is a biopharmaceutical company specializing in the development of drugs and therapeutic products for potential biological threats and infectious diseases. The company focuses on creating medications that could serve as countermeasures in the event of bioterrorism threats or pandemics caused by infectious agents. Their work includes the development of antivirals, anti-radiation, and anti-cholera drugs, all in the context of potential public health emergencies. Shares of SIGA Technologies, Inc. (SIGA) can present an intriguing investment opportunity for investors tracking the advancements in pharmaceuticals and technologies related to biological defense and infectious disease treatment.
Feed
There are no posts to show right now.
We use cookies to improve your experience on our site.
